Skip to main content

Table 2 Main pathogens yielded from blood cultures and relative patterns of resistance between periods

From: Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study

 

Pre-phase

(N = 67, 49.6%)

Post-phase

(N = 68, 50.4%)

Overall

(N = 135)

p-value

Etiology

   

0.06

 Enterobacteriaceae

63 (95.5)

59 (86.8)

122 (91)

0.15

  Klebsiella spp.

39 (61.9)

27 (45.8)

66 (54.1)

 

  E. coli

12 (19.0)

16 (27.1)

28 (23.0)

 

  Enterobacter spp.

8 (12.7)

6 (10.2)

14 (11.5)

 

  Proteus spp.

3 (4.8)

2 (3.4)

5 (4.1)

 

  Serratia spp.

0 (0)

3 (5.1)

3 (2.5)

 

 Pseudomonas spp.

1 (1.5)

7 (10.3)

8 (6.0)

 

 Acinetobacter spp.

1 (1.5)

2 (2.9)

3 (2.2)

 

Pattern of resistance

    

 Wild-type

26 (40.0)

32 (47.1)

58 (43.6)

0.49

 ESBL-E

18 (27.7)

18 (26.5)

36 (27.1)

1

 Carbapenem-resistant

18 (27.7)

11 (16.2)

29 (21.8)

0.14

  KPC

17 (25.4)

8 (11.8)

25 (18.5)

0.002

 DTR

19 (28.4)

15 (22.1)

34 (25.2)

0.32

  1. All values given are n (%) unless otherwise stated
  2. Abbreviations ESBL-E extended spectrum beta-lactamase Enterobacterales, DTR difficult-to-treat resistance